Direct comparison of two different mesal
โ
Hiroaki Ito; Mitsuo Iida; Takayuki Matsumoto; Yasuo Suzuki; Hidetaka Sasaki; Toy
๐
Article
๐
2010
๐
John Wiley and Sons
๐
English
โ 131 KB
๐ 2 views
Background: Mesalamine is the first-line drug for the treatment of ulcerative colitis (UC). We directly compared the efficacy and safety of two mesalamine formulations for the induction of remission in patients with UC. ## Methods: In a multicenter, double-blind, randomized study, 229 patients wit